Cargando…

Role of Cytokines in Experimental and Human Visceral Leishmaniasis

Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there are no effective prophylactic measures and therapeutics available against VL. Recently, new immunotherapy-based approaches have been established for the management of VL. Cytokines, which are predominantly pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samant, Mukesh, Sahu, Utkarsha, Pandey, Satish Chandra, Khare, Prashant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930837/ https://www.ncbi.nlm.nih.gov/pubmed/33680991 http://dx.doi.org/10.3389/fcimb.2021.624009

Ejemplares similares

Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
por: Khare, Prashant, et al.
Publicado: (2020)

Elucidating the role played by bone marrow in visceral leishmaniasis
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2023)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

IL-10 and TGF-β Induced Arginase Expression Contributes to Deficient Nitric Oxide Response in Human Visceral Leishmaniasis
por: Kupani, Manu, et al.
Publicado: (2021)

Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis
por: Hermida, Micely d'El-Rei, et al.
Publicado: (2018)

Apigenin is a promising molecule for treatment of visceral leishmaniasis
por: Emiliano, Yago S. S., et al.
Publicado: (2023)

Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
por: Zijlstra, Eduard E.
Publicado: (2021)

TREM-1 Expression on the Surface of Neutrophils in Patients With Visceral Leishmaniasis Is Associated With Immunopathogenesis
por: Bomfim, Lays Gisele Santos, et al.
Publicado: (2022)

Replacement of Leishmania (Leishmania) infantum Populations in an Endemic Focus of Visceral Leishmaniasis in Brazil
por: Valdivia, Hugo O., et al.
Publicado: (2022)

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis
por: Marlais, Tegwen, et al.
Publicado: (2018)

Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in India
por: Dubey, Pushkar, et al.
Publicado: (2021)

miR-548d-3p Is Up-Regulated in Human Visceral Leishmaniasis and Suppresses Parasite Growth in Macrophages
por: Ramos-Sanchez, Eduardo Milton, et al.
Publicado: (2022)

Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India
por: Bindroo, Joy, et al.
Publicado: (2021)

Understanding Resistance vs. Susceptibility in Visceral Leishmaniasis Using Mouse Models of Leishmania infantum Infection
por: Pérez-Cabezas, Begoña, et al.
Publicado: (2019)

Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum
por: Lévêque, Maude F., et al.
Publicado: (2020)

Corrigendum: miR-548d-3p Is Up-regulated in Human Visceral Leishmaniasis and Suppresses Parasite Growth in Macrophages
por: Ramos-Sanchez, Eduardo Milton, et al.
Publicado: (2022)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020)

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India
por: Cloots, Kristien, et al.
Publicado: (2021)

Case report: Diagnosis of visceral leishmaniasis using metagenomic next-generation sequencing and bone marrow smear
por: Zhang, Xiaogang, et al.
Publicado: (2022)

Case Report: FDG-PET/CT findings in co-infection of visceral leishmaniasis and chronic hepatitis B
por: Feng, Hui, et al.
Publicado: (2023)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Unwinding the mechanism of macrophage repolarization potential of Oceanimonas sp. BPMS22-derived protein protease inhibitor through Toll-like receptor 4 against experimental visceral leishmaniasis
por: Jayaraman, Adithyan, et al.
Publicado: (2023)

Evaluation of Loopamp™ Leishmania Detection Kit and Leishmania Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh
por: Hossain, Faria, et al.
Publicado: (2021)

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2022)

Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments
por: Magalhães, Lucas Sousa, et al.
Publicado: (2022)

DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis
por: Pandey, Satish Chandra, et al.
Publicado: (2020)

Leishmania infantum infecting the carnivore Nasua nasua from urban forest fragments in an endemic area of visceral leishmaniasis in Brazilian Midwest
por: de Macedo, Gabriel Carvalho, et al.
Publicado: (2023)

Editorial: Immunology and immunopathogenesis of human leishmaniasis
por: de Menezes, Juliana P. B., et al.
Publicado: (2022)

Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis
por: Terra, Rodrigo, et al.
Publicado: (2019)

Corrigendum: Leishmania infantum infecting the carnivore Nasua nasua from urban forest fragments in an endemic area of visceral leishmaniasis in Brazilian Midwest
por: de Macedo, Gabriel Carvalho, et al.
Publicado: (2023)

An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy
por: Gonçalves, Ana Alice Maia, et al.
Publicado: (2019)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Editorial: Biomarkers in Leishmaniasis
por: Carrillo, Eugenia, et al.
Publicado: (2019)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression
por: Saldanha, Maíra Garcia, et al.
Publicado: (2020)

Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fuupn5no9n5jhoev4eq7u1nut2